2 false false false false false false false false false false true false false false false true true false 2023-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 11,008,871 10,687 11,019,558 11,019,558 11,008,871 xbrli:pure xbrli:shares iso4217:EUR 09453002 2023-01-01 2023-12-31 09453002 2023-12-31 09453002 2022-12-31 09453002 2022-01-01 2022-12-31 09453002 2022-12-31 09453002 2021-12-31 09453002 bus:Director1 2023-01-01 2023-12-31 09453002 bus:Director2 2023-01-01 2023-12-31 09453002 bus:CompanySecretary1 2023-01-01 2023-12-31 09453002 core:WithinOneYear 2023-12-31 09453002 core:WithinOneYear 2022-12-31 09453002 core:RetainedEarningsAccumulatedLosses 2022-01-01 2022-12-31 09453002 core:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 09453002 core:ShareCapital 2023-12-31 09453002 core:ShareCapital 2022-12-31 09453002 core:RetainedEarningsAccumulatedLosses 2023-12-31 09453002 core:RetainedEarningsAccumulatedLosses 2022-12-31 09453002 core:ShareCapital 2021-12-31 09453002 core:RetainedEarningsAccumulatedLosses 2021-12-31 09453002 core:CostValuation core:Non-currentFinancialInstruments 2022-12-31 09453002 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInInvestments 2023-12-31 09453002 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 09453002 core:Non-currentFinancialInstruments 2023-12-31 09453002 core:Non-currentFinancialInstruments 2022-12-31 09453002 bus:SmallEntities 2023-01-01 2023-12-31 09453002 bus:AuditExempt-NoAccountantsReport 2023-01-01 2023-12-31 09453002 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 09453002 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 09453002 bus:FullAccounts 2023-01-01 2023-12-31
COMPANY REGISTRATION NUMBER: 09453002
GENESIS HOLDING LIMITED
Unaudited Financial Statements
31 December 2023
GENESIS HOLDING LIMITED
Financial Statements
Year ended 31 December 2023
Contents
Page
Directors' report
1
Income statement
2
Statement of financial position
3
Statement of changes in equity
4
Notes to the financial statements
5
GENESIS HOLDING LIMITED
Directors' Report
Year ended 31 December 2023
The directors present their report and the unaudited financial statements of the company for the year ended 31 December 2023 .
Principal activities
The principal activity of the company during the year was holding of investments.
Directors
The directors who served the company during the year were as follows:
Fiduci-Corp Directors Limited
Mrs Kyproulla Karantoni
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 3 April 2024 and signed on behalf of the board by:
Fiduci-Corp Directors Limited
Mrs Kyproulla Karantoni
Director
Director
Fiduci-Corp (UK) Services Limited
Company Secretary
GENESIS HOLDING LIMITED
Income Statement
Year ended 31 December 2023
2023
2022
Note
Administrative expenses
( 31,485)
( 32,787)
--------
--------
Operating loss
( 31,485)
( 32,787)
Income from other fixed asset investments
( 472)
( 1,033)
Other interest receivable and similar income
10,693
50,131
Interest payable and similar expenses
( 33)
( 8)
--------
--------
(Loss)/profit before taxation
( 21,297)
16,303
Tax on (loss)/profit
( 9,194)
--------
--------
(Loss)/profit for the financial year
( 21,297)
7,109
--------
--------
All the activities of the company are from continuing operations.
The company has no other recognised items of income and expenses other than the results for the year as set out above.
GENESIS HOLDING LIMITED
Statement of Financial Position
31 December 2023
2023
2022
Note
Fixed assets
Investments
5
11,019,558
11,008,871
Current assets
Debtors
6
71,804
71,819
Investments
7
472
Cash at bank and in hand
2,038
2,033
--------
--------
73,842
74,324
Creditors: amounts falling due within one year
8
406,890
375,388
---------
---------
Net current liabilities
333,048
301,064
-------------
-------------
Total assets less current liabilities
10,686,510
10,707,807
-------------
-------------
Net assets
10,686,510
10,707,807
-------------
-------------
Capital and reserves
Called up share capital
2,412,602
2,412,602
Profit and loss account
8,273,908
8,295,205
-------------
-------------
Shareholders funds
10,686,510
10,707,807
-------------
-------------
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 3 April 2024 , and are signed on behalf of the board by:
Fiduci-Corp Directors Limited
Mrs Kyproulla Karantoni
Director
Director
Company registration number: 09453002
GENESIS HOLDING LIMITED
Statement of Changes in Equity
Year ended 31 December 2023
Called up share capital
Profit and loss account
Total
At 1 January 2022
2,412,602
11,288,096
13,700,698
Profit for the year
7,109
7,109
------------
-------------
-------------
Total comprehensive income for the year
7,109
7,109
Dividends paid and payable
( 3,000,000)
( 3,000,000)
------------
-------------
-------------
Total investments by and distributions to owners
( 3,000,000)
( 3,000,000)
At 31 December 2022
2,412,602
8,295,205
10,707,807
Loss for the year
( 21,297)
( 21,297)
------------
-------------
-------------
Total comprehensive income for the year
( 21,297)
( 21,297)
------------
-------------
-------------
At 31 December 2023
2,412,602
8,273,908
10,686,510
------------
-------------
-------------
GENESIS HOLDING LIMITED
Notes to the Financial Statements
Year ended 31 December 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is St Georges House, 6th Floor, 15 Hanover Square, London, W1S 1HS, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss. The financial statements are prepared in euro, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying entity as defined in FRS 102. As such, advantage has been taken of the following disclosure exemptions available under paragraph 1.12 of FRS 102: (a) No cash flow statement has been presented for the company.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2022: 2 ).
5. Investments
Other loans
Cost
At 1 January 2023
11,008,871
Other movements
10,687
-------------
At 31 December 2023
11,019,558
-------------
Impairment
At 1 January 2023 and 31 December 2023
-------------
Carrying amount
At 31 December 2023
11,019,558
-------------
At 31 December 2022
11,008,871
-------------
6. Debtors
2023
2022
Prepayments and accrued income
298
313
Other debtor - assignement agreement
65,196
65,196
Other debtors
6,310
6,310
--------
--------
71,804
71,819
--------
--------
7. Investments
2023
2022
Portfolio
472
----
----
8. Creditors: amounts falling due within one year
2023
2022
Trade creditors
31,294
15,787
Accruals and deferred income
53,189
37,257
Corporation tax
9,194
Other creditors
322,407
313,150
---------
---------
406,890
375,388
---------
---------
9. Related party transactions
Emineo Limited is the sole shareholder.